Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

9.49
Delayed Data
As of Dec 10
 -0.33 / -3.36%
Today’s Change
6.07
Today|||52-Week Range
20.21
-38.46%
Year-to-Date

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 8.50, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a -10.43% decrease from the last price of 9.49.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.61
Sales
$4.4B
Reporting Date
Feb 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.83%
 
 
 
 
 
 
Growthannually -18.37%
 
 
 
 
 
 

Sales

Growthquarterly 2.11%
 
 
 
 
 
 
Growthannually -8.70%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.